abbreviations - Cancer Research and Biostatistics
advertisement
SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A REVISED: OCTOBER 2015 ABBREVIATIONS The following list contains abbreviations and symbols commonly encountered in medical documentation. It is not intended to be an all-inclusive listing of medical definitions. This list is designed to be a resource document for the data manager and may be used as an aid in the transcription of information from the patient's chart to SWOG documentation.1 ABBREVIATION DEFINITION ABBREVIATION DEFINITION a before B(R or L)CM @ at below (right or left) costal margin abd abdominal bid twice daily abnl abnormal bilat bilateral abx antibiotics bili bilirubin ADR adverse drug reaction B-J Bence Jones afeb afebrile, without fever bld blood BMT a fib atrial fibrillation bone marrow transplant adj adjuvant, postoperative B/O because of BS AGC absolute granulocyte count bowel sounds, breath sounds BSA body surface area alk agents alkylating agents BT bladder tumor alp, alk phos, alk p'tase alkaline phosphatase BUN blood urea nitrogen alt alternate Bx biopsy amt amount c with ant anterior C caucasian A-P anteroposterior Ca cancer A&P auscultation and percussion CAD coronary artery disease as tol as tolerated calc calculated asx asymptomatic cath catheter avg average CBC complete blood count b/c because cc chief complaint BC blood culture CEA carcinoembryonic antigen 1 Abbreviation list primarily contributed by Kelly Kelso, Research Coordinator at the Christ Hospital Cancer Center Appendix A - Page 1 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A REVISED: OCTOBER 2015 cgy centigray (radiation dose unit) DNKA did not keep appointment CIS carcinoma in situ drsg,dsg dressing CI continuous infusion dt date CNS central nervous system DTR deep tendon reflexes c/o complaint of dx,diag diagnosis coag coagulation DVT deep vein thrombosis CR complete response dz disease Creat creatinine ea each CrCl creatinine clearance EENT eyes, ears, nose, throat C&S culture and sensitivity EF ejection fraction CSF cerebrospinal fluid e'lytes electrolytes C spine cervical spine EM electron microscopy CV cardiovascular EOM extraocular movement c/w consistent with equiv equivalent cx culture ESRD CXR chest x-ray end stage renal disease cysto cystoscopy etiol etiology cytol cytology ETOH alcohol d or /d day or per day exp lap exploratory laparotomy dbl double FBS/FBG fasting blood sugar/glucose d/c discontinue, discharge FEF forced expiratory flow diag,dx diagnosis FEV, FEV1 DIC diffuse intravascular coagulation forced expiratory volume, -in one second diff differential FFP fresh frozen plasma DJD degenerative joint disease FH,FHx family history fib fibrillation FIGO International Federation of Obstetricians and Gynecologists FMOL femtomoles DOB date of birth DOE dyspnea on exertion DLCO diffuse capacity (of lung) for carbon monoxide Appendix A - Page 2 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A REVISED: OCTOBER 2015 FS frozen section h/o history of FTSG full thickness skin graft H&P history and physical f/u follow up hpf high power field FUO fever of unknown origin HPI history of present illness FVC forced vital capacity hr hour fx fracture HR heart rate GI gastrointestinal HS heart sounds glu glucose hs bedtime, hour of sleep GP general practitioner ht height gtt drops HTN,HPN hypertension GVHD graft versus host disease hx history IA intra arterial Gy gray (radiation dose unit)=1000 cgy id identification Gyn gynecology IDDM insulin dependent diabetes mellitus GU genitourinary Ig immunoglobulin HA headache imp improved HBsAg hepatitis B surface antigen inc increasing HCL hairy cell leukemia IND investigational new drug Hct hematocrit infx,infect infection H&E hematoxylin and eosin stain ing inguinal HEENT head, eyes, ears, nose, throat inop inoperable inpt inpatient hem hematology, blood int internal Hgb hemoglobin IP intra peritoneal HLA histocompatibility leukocyte antigen IPPB HLA-DR human histocompatibility leukocyte antigen isol intermittent positive pressure breathing isolation IU international units IVP intravenous pyelogram KUB kidney, ureters, bladder H&N head and neck HO house officer Appendix A - Page 3 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A REVISED: OCTOBER 2015 N/C no change N/D not done NED no evidence of disease lateral neg negative lbs pounds neuro neurological LE(LLE,RLE) lower extremity, (left or right) NHL non Hodgkin's lymphoma LEF left ejection fraction NKA no known allergies lg large nl normal LLN lower limit of normal NOS LQ(LLQ,RLQ) lower quadrant, (left or right) not otherwise specified NRBC LMD local physician nucleated red blood cells LMP last menstrual period NS no show LOA leave of absence NSC no significant change LP lumbar puncture NSR normal sinus rhythm LS lumbar spine, lumbosacral N/V/(D) nausea/vomiting/ (diarrhea) L/S liver, spleen onco oncology LUL left upper lobe OD right eye LUO left ureteral orifice op operative report, operation LUQ left upper quadrant orig original lytes electrolytes OS left eye max maximum OU both eyes mcg microgram O/W otherwise mEq milliequivalent p after met metastasis P&A MF mycosis fungoides percussion and auscultation MI myocardial infarction path pathology MUGA multiple gated acquisition scanning PBS peripheral blood smear PD progressive disease NAD no apparent distress PE physical exam N/A not applicable PFT pulmonary function test LAK cells lymphokine activated killer cells lap laparoscopy, laparotomy lat Appendix A - Page 4 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A REVISED: OCTOBER 2015 PH,PHx prior history qowk every other week plt platelet qwk every week PMH prior medical history R right PMI prior medical illnesses r recombinant pmn,poly polymorphonuclear neutrophil re: regarding po by mouth, orally req request ppd pack per day (cigarettes) resp respiratory, respirations PR partial response RLL right lower lobe PRBC packed red blood cells RLQ right lower quadrant prn as needed R/O rule out PT prothrombin time ROS review of systems PTT partial thromboplastin time RPC Radiological Physics Center pt patient RR respiration rate, regular rate PUD peptic ulcer disease RRR pulm pulmonary regular rate and rhythm PUVA psoralen with long wavelength ultraviolet light RSR regular sinus rhythm RT radiation therapy PVC premature ventricular contraction RTC,RTO return to clinic, return to office pvt private rtn routine py pack year (cigarettes) RUE right upper extremity q every RUL right upper lobe QAC Quality Assurance Center (for RT) RUO right ureteral orifice RUQ right upper quadrant qam every morning Rx qd every day s treatment, prescription without qh every hour SOB shortness of breath qhs every bedtime SEF surgical evaluation form qid four times daily SEM qod every other day systolic ejection murmur SIJ sacroiliac joint Appendix A - Page 5 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS sm small soln solution s/p APPENDIX A REVISED: OCTOBER 2015 TRAP tartrate-resistent leukocyte acid phosphatase after (status post) T spine thoracic spine spec specimen TUR,-BT,-P sp fl spinal fluid transurethral resection,-of bladder tumor,-of prostate srg surgery tx treatment, therapy s/s signs and symptoms UE upper extremities ssf surgical summary form UGI upper gastrointestinal std standard ULN upper limit of normal STSG split thickness skin graft unk unknown Sx symptoms U/L upper and lower syn syndrome URI upper respiratory infection sys systemic, systemic therapy urol urology syst systemic, systolic UTI urinary tract infection sz seizure vasc vascular T temperature vert vertebrae, vertebral TAH/BSO total abdominal hysterectomy/bilateral salpingo oophorectomy via by way of vit vitamin TCC transitional cell carcinoma VS vital signs v-tach temp temperature ventricular tachycardia TIBC total iron binding capacity w/ with WB whole blood tid three times daily WD well developed TM tympanic membranes WF white female Tmax maximum temperature (usually for 24 hours) w/i within tol tolerated wk week tox toxicity WM white male tp total protein WN well nourished WNL within normal limits w/o without Appendix A - Page 6 ORP Manual, Volume I Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A WPRBC washed packed red blood cells wt weight x except x by (used with dimensions, eg. 1x2) XRT radiation therapy y/o years old Appendix A - Page 7 ORP Manual, Volume I REVISED: OCTOBER 2015 Version 2.0 SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I ABBREVIATIONS APPENDIX A SYMBOL DEFINITION ↑ increase ↓ decrease female male √ up check-up 2° (to) secondary (to) ∆ change no ∆ no change > greater than ≥ greater than or equal to < ≤ Appendix A - Page 8 REVISED: OCTOBER 2015 SYMBOL DEFINITION @ at # number / per + positive - negative R right L left n° (n=1 thru 12) hour (measure of time, e.g., 1 hour after dinner) α alpha β beta less than γ gamma less than or equal to µ mu (micro) ORP Manual, Volume I Version 2.0
